v3.26.1
Equity (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Share Activity
The table below outlines the share activity:

Three months ended March 31,
20262025
Shares of common stock issued in settlement of vested RSUs and options exercised1
4,369,135 7,480,021 
Reduction of shares of common stock issued2
(1,699,845)(3,189,611)
Issuance of shares of common stock for equity-based awards2,669,290 4,290,410 
1 The gross value of shares issued was $568 million and $1,234 million for the three months ended March 31, 2026 and 2025, respectively, based on the closing price of the shares of common stock at the time of issuance.
2 Cash paid for tax liabilities associated with net share settlement was $225 million and $528 million for the three months ended March 31, 2026 and 2025, respectively.
Schedule of Quarterly Dividends and Distributions
Outlined below is information regarding quarterly dividends and distributions (in millions, except per share data).

Dividend Declaration DateDividend per Share of Common StockPayment DateDividend to Common StockholdersDistribution Equivalents on Participating Securities
February 4, 2025$0.46 February 28, 2025$264 $14 
May 2, 20250.51 May 30, 2025292 14 
August 5, 20250.51 August 29, 2025291 15 
November 4, 20250.51 November 28, 2025296 15 
Year ended December 31, 2025$1.99 $1,143 $58 
February 9, 2026$0.51 February 27, 2026$295 $17 
Three months ended March 31, 2026$0.51 $295 $17 
Schedule of Accumulated Other Comprehensive Income (Loss)
(In millions)Unrealized investment gains (losses) on AFS securities without a credit allowanceUnrealized investment gains (losses) on AFS securities with a credit allowanceUnrealized gains (losses) on hedging instrumentsRemeasurement gains (losses) on future policy benefits related to discount rateRemeasurement gains (losses) on market risk benefits related to credit riskForeign currency translation and other adjustmentsAccumulated other comprehensive income (loss)
Balance at December 31, 2025$(6,372)$(252)$(17)$4,137 $(169)$28 $(2,645)
Other comprehensive income (loss) before reclassifications(2,110)(14)137 909 216 (30)(892)
Less: Reclassification adjustments for gains (losses) realized1
(61)(9)— — — (63)
Less: Income tax provision (benefit)(406)(1)28 186 45 (8)(156)
Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax(415)(7)229 30 (15)(174)
Balance at March 31, 2026$(7,600)$(249)$81 $4,631 $(28)$21 $(3,144)
1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations.

(In millions)Unrealized investment gains (losses) on AFS securities without a credit allowanceUnrealized investment gains (losses) on AFS securities with a credit allowanceUnrealized gains (losses) on hedging instrumentsRemeasurement gains (losses) on future policy benefits related to discount rateRemeasurement gains (losses) on market risk benefits related to credit riskForeign currency translation and other adjustmentsAccumulated other comprehensive income (loss)
Balance at December 31, 2024$(9,174)$(284)$(119)$4,235 $(103)$(49)$(5,494)
Other comprehensive income (loss) before reclassifications1,338 (37)239 (528)116 63 1,191 
Less: Reclassification adjustments for gains (losses) realized1
(191)— 10 — — — (181)
Less: Income tax provision (benefit)312 (8)48 (110)24 273 
Less: Other comprehensive income (loss) attributable to non-controlling interests, net of tax260 — 62 (169)12 23 188 
Balance at March 31, 2025$(8,217)$(313)$— $3,986 $(23)$(16)$(4,583)
1 Recognized in investment related gains (losses) on the condensed consolidated statements of operations.